论文部分内容阅读
在第11届欧洲临床微生物学和传染病大会上,研究人员报道了一项Ⅱ期研究结果,即免疫反应修饰因子是一类有望治疗生殖器疱疹的药物。
At the 11th European Congress of Clinical Microbiology and Infectious Diseases, researchers reported the results of a phase II study of immunomodulatory modifiers as a class of drugs that are expected to treat genital herpes.